Asia-pacific Journal of Clinical Oncology
Papers 1,923
1 page of 193 pages (1,923 results)
#1Jiao Zhang (SDU: Shandong University)
Last. Wujie Wang (SDU: Shandong University)H-Index: 8
view all 4 authors...
PURPOSE The optimal microparticle size for drug-eluting beads transarterial chemoembolization (DEB-TACE) remains unknown. This retrospective cohort study analyzed the efficacy and safety of CalliSpheres microsphere embolization in the treatment of unresectable hepatocellular carcinoma (HCC) to determine the influence of particle size on the results. PATIENTS AND METHODS Forty-two patients with unresectable HCC were enrolled in this retrospective study from January 2018 to January 2020. Patients ...
#1Naoya IshibashiH-Index: 8
#2Toshiya MaebayashiH-Index: 9
Last. Masahiro OkadaH-Index: 25
view all 5 authors...
#1Naveera Zafar (Aga Khan University)H-Index: 1
#2Kulsoom Ghias (Aga Khan University)H-Index: 10
Last. Zehra Fadoo (Aga Khan University)H-Index: 11
view all 3 authors...
Globally, 15-20% of all children diagnosed with leukemia suffer from acute myeloid leukemia (AML), a rapidly progressive, clinically and biologically heterogeneous disease leading to the impaired differentiation of myeloid blast cells. Although 80% of patients achieve complete remission after induction chemotherapy, many relapse, negatively affecting overall out comes. The mechanisms underlying relapse have not been fully elucidated. This review aims to provide an overview of genetic aberrations...
#1Huimin Hu (Capital Medical University)H-Index: 13
#2Weiling Zhang (Capital Medical University)H-Index: 5
Last. Dongsheng Huang (Capital Medical University)H-Index: 8
view all 8 authors...
AIMS To analyze the factors affecting the prognosis of hepatoblastoma (HB) with lung metastasis in children. METHODS The HB patients with lung metastases admitted to Beijing Tongren Hospital, Capital Medical University were collected. The clinical data, overall results, and prognostic factors were analyzed. Multivariate analysis was done by the Cox proportional hazards model for patients' prognosis. RESULTS Finally, 98 HB patients (64 boys and 34 girls) with lung metastasis met the inclusion cri...
#1Abdilkerim Oyman (UHSA: University of Health Sciences Antigua)H-Index: 2
#2Mustafa BasakH-Index: 2
Last. Mahmut Emre YıldırımH-Index: 3
view all 6 authors...
Purpose The aim of this study was to evaluate the efficacy of abiraterone in patients with castration-resistant metastatic prostate cancer. Materials and methods We retrospectively analyzed 51 patients with mCRPC treated with abiraterone acetate from January 2014 to August 2018. Clinicopathological information, treatment modalities, treatment responses, and survival times were retrospectively reviewed. Results A total of 51 patients who received abiraterone 1000 mg/day + prednisone 10 mg/day bet...
#1Tetsuhide Ito (International University of Health and Welfare)H-Index: 3
#2Nao Fujimori (Kyushu University)H-Index: 13
Last. Akira ShimatsuH-Index: 23
view all 11 authors...
Aim The aim of this study was to describe the long-term safety and efficacy of lanreotide in Japanese patients with neuroendocrine tumors. Methods The final analyses of a 48-week open-label phase II study (n = 32) and its extension study (n = 17) were conducted. Patients received 4-weekly subcutaneous injections of lanreotide autogel 120 mg. Safety was evaluated by adverse events. Efficacy endpoints included tumor response by RECIST and change in tumor size. Post hoc analyses including tumor gro...
AIMS To integrate primary care into multidisciplinary cancer meetings and improve communication between hospital- and community-based care providers. METHODS A 12-week pilot study was conducted at Western Health, implementing a model of care, where two general practitioners (GPs) were recruited from the local community to attend weekly breast and lung multidisciplinary meetings in a liaison role as a primary care representative (PCR). Community GPs and hospital specialists were surveyed at the e...
#1Kennedy Yao Yi NgH-Index: 3
#2Lawrence Wen Jun Wong (NUS: National University of Singapore)H-Index: 2
view all 7 authors...
Introduction Immune checkpoint inhibitor (ICI) use in advanced hepatocellular carcinoma (HCC) is increasing. Real-world data on efficacy and safety, however, are lacking. Methods We conducted a retrospective review of all patients with advanced HCC seen at our center who received at least one dose of an ICI between May 2015 and June 2018. Data cutoff was December 31, 2018. Responses were evaluated using Response Evaluation Criteria in Solid Tumors version 1.1 criteria. Results Of 114 patients, 8...
#2Ming Hui Yong (SGH: Singapore General Hospital)H-Index: 2
Last. Quan Sing NgH-Index: 23
view all 8 authors...
Immune checkpoint inhibitors (ICI) have improved survival across tumor types however they cause immune-related toxicities through removal of the inhibition of auto-reactive T cells. In this case review, we present 4 patients with metastatic cancer who developed de-novo neuromuscular side effects of myositis with overlapping seropositive myasthenia gravis after ICI treatment. Declaration: This study was performed in accordance to the ethical standards set by the SingHealth Institutional Review Bo...
#1Qin Wang (Nanjing Medical University)
#2Jiefang Ding (Nanjing Medical University)
Last. Rusong Yang (Nanjing Medical University)
view all 3 authors...
OBJECTIVES Venous thromboembolism (VTE) is a significant and preventable cause of mortality and morbidity in thoracic surgery. It usually deep venous thromboembolism (DVT) and pulmonary thromboembolism (PE). We conducted this article to perform a systematic review on prophylaxis of perioperative VTE in patients undergoing thoracic surgery especially lung surgery and esophageal surgery and to identify potential areas for future research. METHODS The systematic review we conducted included studies...
Top fields of study
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.